Acquisition Announced

ACS Dobfar acquisition of Istituto Biochimico Italiano Giovanni Lorenzini (IBI Lorenzini)

Announced 2026 (approx.)

Advisers

Istituto Biochimico Italiano Giovanni Lorenzini (IBI Lorenzini)

Target

Financial adviser

ACS Dobfar

Acquirer

Not disclosed

Target
Istituto Biochimico Italiano Giovanni Lorenzini (IBI Lorenzini)
Acquirer
ACS Dobfar
Target based in
Italy
Buyer based in
Italy
Sector
Pharmaceutical Manufacturing
Tags
Pharmaceutical Manufacturing, Pharma

Similar deals

All pharmaceutical manufacturing deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.